No abstract available
Keywords:
DMARDs (biologic); anti-TNF; disease activity; outcomes research.
MeSH terms
-
Antirheumatic Agents*
-
Biosimilar Pharmaceuticals*
-
Etanercept
-
Humans
-
Registries
-
Treatment Outcome
Substances
-
Antirheumatic Agents
-
Biosimilar Pharmaceuticals
-
Etanercept